These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 31165274

  • 21. Phyto-glycosides as Therapeutic Target in the Treatment of Diabetes.
    Khattak S, Khan H.
    Mini Rev Med Chem; 2018; 18(3):208-215. PubMed ID: 27629995
    [Abstract] [Full Text] [Related]

  • 22. Synthesis, enzyme kinetics and computational evaluation of N-(β-D-glucopyranosyl) oxadiazolecarboxamides as glycogen phosphorylase inhibitors.
    Polyák M, Varga G, Szilágyi B, Juhász L, Docsa T, Gergely P, Begum J, Hayes JM, Somsák L.
    Bioorg Med Chem; 2013 Sep 15; 21(18):5738-47. PubMed ID: 23938052
    [Abstract] [Full Text] [Related]

  • 23. Identification of Flavonoid C-Glycosides as Promising Antidiabetics Targeting Protein Tyrosine Phosphatase 1B.
    Rampadarath A, Balogun FO, Pillay C, Sabiu S.
    J Diabetes Res; 2022 Sep 15; 2022():6233217. PubMed ID: 35782627
    [Abstract] [Full Text] [Related]

  • 24. Naturally occurring sulfonium-ion glucosidase inhibitors and their derivatives: a promising class of potential antidiabetic agents.
    Mohan S, Eskandari R, Pinto BM.
    Acc Chem Res; 2014 Jan 21; 47(1):211-25. PubMed ID: 23964564
    [Abstract] [Full Text] [Related]

  • 25. Synthesis of N-glucopyranosidic derivatives as potential inhibitors that bind at the catalytic site of glycogen phosphorylase.
    Gimisis T.
    Mini Rev Med Chem; 2010 Oct 21; 10(12):1127-38. PubMed ID: 20716054
    [Abstract] [Full Text] [Related]

  • 26. Advances in glycogen phosphorylase inhibitor design.
    Oikonomakos NG, Somsák L.
    Curr Opin Investig Drugs; 2008 Apr 21; 9(4):379-95. PubMed ID: 18393105
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A convenient synthesis of novel pyranosyl homo-C-nucleosides and their antidiabetic activities.
    Bisht SS, Jaiswal N, Sharma A, Fatima S, Sharma R, Rahuja N, Srivastava AK, Bajpai V, Kumar B, Tripathi RP.
    Carbohydr Res; 2011 Jul 15; 346(10):1191-201. PubMed ID: 21550025
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. N-Indolylglycosides bearing modifications at the glucose C6-position as sodium-dependent glucose co-transporter 2 inhibitors.
    Chu KF, Yao CH, Song JS, Chen CT, Yeh TK, Hsieh TC, Huang CY, Wang MH, Wu SH, Chang WE, Chao YS, Lee JC.
    Bioorg Med Chem; 2016 May 15; 24(10):2242-50. PubMed ID: 27075813
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Antidiabetic Naphthoquinones and Their Plant Resources in Thailand.
    Shah MA, Keach JE, Panichayupakaranant P.
    Chem Pharm Bull (Tokyo); 2018 May 15; 66(5):483-492. PubMed ID: 29710045
    [Abstract] [Full Text] [Related]

  • 39. Recent advances in the allosteric inhibition of glycogen phosphorylase.
    Loughlin WA.
    Mini Rev Med Chem; 2010 Oct 15; 10(12):1139-55. PubMed ID: 20716052
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.